Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Somatic mutations have a role in the pathogenesis of a number of diseases, particularly cancers. Here we present data supporting a role of mitochondrial somatic mutations in an autoimmune disease, rheumatoid arthritis (RA). RA is a complex, multifactorial disease with a number of predisposition traits, including major histocompatibility complex (MHC) type and early bacterial infection in the joint. Somatic mutations in mitochondrial peptides displayed by MHCs may be recognized as non-self, furthering the destructive immune infiltration of the RA joint. Because many bacterial proteins have mitochondrial homologues, the immune system may be primed against these altered peptides if they mimic bacterial homologues. In addition, somatic mutations may be influencing cellular function, aiding in the acquirement of transformed properties of RA synoviocytes. To test the hypothesis that mutations in mitochondrial DNA (mtDNA) are associated with RA, we focused on the MT-ND1 gene for mitochondrially encoded NADH dehydrogenase 1 (subunit one of complex I – NADH dehydrogenase) of synoviocyte mitochondria from RA patients, using tissue from osteoarthritis (OA) patients for controls. We identified the mutational burden and amino acid changes in potential epitope regions in the two patient groups. RA synoviocyte mtDNA had about twice the number of mutations as the OA group. Furthermore, some of these changes had resulted in potential non-self MHC peptide epitopes. These results provide evidence for a new role for somatic mutations in mtDNA in RA and predict a role in other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some of the non-synonymous changes within MT-ND1 generated predicted epitopes for RA-predisposing MHC class II alleles (HLA-DRβ1*0101 and HLA-DRβ1*0401), suggesting a role for these mutations in RA pathogenesis44”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“one study reported an increase in the frequency of mtDNA somatic mutations in synoviocytes from patients with RA compared with synoviocytes from patients with OA44”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sequence and organization of the human mitochondrial genome
Anderson, S., Bankier, A. T., Barrell, B. G., de Bruijn, M. H. L., Coulson, A. R., Drouin, J., Eperon, I. C., Nierlich, D. P., Roe, B. A., Sanger, F., et al. (1981) · Nature · doi:10.1038/290457a0 · Cited by 9,636 · cited 2×
“Both forward and reverse primers in addition to the specific nucleotide sequence have a corresponding M13 tag (M13F, 5'-TGTAAAACGACGGCCAGT- 3' ; M13R, 5'-CAGGAAACAGCTATGACC-3'); start position numbering represents location of 5' end corresponding to the Anderson Reference Sequence [17].”
BackgroundMethodEvolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,605 · cited 3×
“While these mutations are most likely a consequence of inflammation and not the cause of RA, they would be expected to affect disease progression [1].”
BackgroundInfluentialMitochondrial genome variation and the origin of modern humans
Ingman, M., Kaessmann, H., Pääbo, S., & Gyllensten, U. (2000) · Nature · doi:10.1038/35047064 · Cited by 1,551 · cited 1×
“The NCBI reference sequence (gi:17981852) also shows a deletion at this position when compared with the Anderson sequence (where there is a C) [20].”
BackgroundWolfe, F., & Michaud, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20311 · Cited by 644 · cited 1×
“A higher incidence of lymphoma is also well documented in RA, and somatic mutations may lead to enhancement of the aggressive nature of pathogenic cells [25].”
BackgroundMüller‐Ladner, U., Kriegsmann, J., Franklin, B. N., Matsumoto, S., Geiler, T., Gay, R. E., & Gay, S. (1996) · Europe PMC (PubMed Central) · Cited by 606
Pitkanen, S., & Robinson, B. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118798 · Cited by 388 · cited 1×
“Cells with complex I defects have also been shown to produce a higher amount of superoxide in vivo [8,13].”
BackgroundSomatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium
Firestein, G. S., Echeverri, F., Yeo, M., Zvaifler, N. J., & Green, D. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10895 · Cited by 377 · cited 2×
“Certain mutations within p53 then confer a survival advantage to the synoviocytes, giving them 'transformed' characteristics and participating in the perpetuation of disease [5].”
BackgroundLafyatis, R., Remmers, E. F., Roberts, A. B., Yocum, D. E., Sporn, M. B., & Wilder, R. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114011 · Cited by 323 · cited 1×
“RA synovial fibroblasts have many features of transformed cells – including the expression of oncogenes – and they have been shown to invade and destroy cartilage in the absence of T cells [2,3].”
BackgroundLoveland, B. (1990) · Cell · doi:10.1016/0092-8674(90)90345-f · Cited by 320 · cited 1×
“The maternally transmitted antigen of rats and mice is the product of a class I molecule that presents the maternal transplantation factor derived from the amino terminus of mtND1 [14].”
BackgroundIdentification of HLA-A2–restricted CD8+ Cytotoxic T Cell Responses in Primary Biliary Cirrhosis
Kita, H., Lian, Z.-X., Van de Water, J., He, X.-S., Matsumura, S., Kaplan, M., Luketic, V., Coppel, R. L., Ansari, A. A., & Gershwin, M. E. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010956 · Cited by 292 · cited 1×
“There is growing evidence that somatic mutations within protein-coding genes of mtDNA may be recognized by the immune system: damaged mtDNA results in increased expression of MHC class I; and both MHC class I and class II can present mitochondrial peptides [11,12].”
BackgroundMáximo, V., Soares, P., Lima, J., Cameselle-Teijeiro, J., & Sobrinho-Simões, M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61132-7 · Cited by 271
Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases
Tak, P. P., Zvaifler, N. J., Green, D. R., & Firestein, G. S. (2000) · Immunology Today · doi:10.1016/s0167-5699(99)01552-2 · Cited by 268 · cited 2×
“The acquisition of these transformed characteristics is thought to be aided by increased somatic mutations caused by reactive oxygen species (ROS) and reactive nitrogen species (RNS) produced endogenously within the inflamed joint [4].”
BackgroundLee, H.-C., Li, S.-H., Lin, J.-C., Wu, C.-C., Yeh, D.-C., & Wei, Y.-H. (2004) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2003.12.011 · Cited by 260 · cited 1×
“Alterations of mtDNA are now being found in many tumor types and there is evidence that these mutations may contribute to the progression of human cancer [9,10].”
BackgroundMHCPred: a server for quantitative prediction of peptide-MHC binding
Guan, P. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg510 · Cited by 260 · cited 2×
“Given an amino acid sequence, the program predicts the peptides likely to bind to the MHC complex (epitopes) and their IC50 values [21].”
BackgroundMethodMtDNA mutations in aging and apoptosis
Chomyn, A., & Attardi, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00625-9 · Cited by 243 · cited 2×
“There is limited and sometimes contradictory evidence available concerning the ability of mtDNA mutations to lead to increased or decreased apoptosis [8].”
BackgroundRegional analysis of p53 mutations in rheumatoid arthritis synovium
Yamanishi, Y., Boyle, D. L., Rosengren, S., Green, D. R., Zvaifler, N. J., & Firestein, G. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152333199 · Cited by 214 · cited 2×
“Their mutations would be predicted to give a growth advantage to the mutated cells, leading to monoclonal expansion [6].”
BackgroundThe role of apoptosis in rheumatoid arthritis
Liu, H. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00037-7 · Cited by 199 · cited 2×
“The mutated p53 was a dominant negative, suggesting that p53 mutations help protect pathogenic cells from apoptosis [5-7].”
BackgroundMitochondrial mutational spectra in human cells and tissues
Khrapko, K., Coller, H. A., André, P. C., Li, X.-C., Hanekamp, J. S., & Thilly, W. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13798 · Cited by 182 · cited 1×
“Together, these attributes make mtDNA highly prone to damage by ROS produced by both mitochondria and exogenous sources [24].”
BackgroundTaylor, R. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.15.e74 · Cited by 173 · cited 1×
“described in Table 1 and have been published previously [16].”
Somatic mutation in the tumore suppressor gene in erosive rheumatoid arthritis synovium
Firestein, G. (1997) · Medical Entomology and Zoology · Cited by 123
Dihydrolipoamide Dehydrogenase-binding Protein of the Human Pyruvate Dehydrogenase Complex
Harris, R. A., Bowker-Kinley, M. M., Wu, P., Jeng, J., & Popov, K. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.19746 · Cited by 110 · cited 1×
“The gene, DLD, was chosen because its product, dihydrolipoamide dehydrogenase, is a nuclear-encoded mitochondrial subunit peptide, constitutively expressed in all cell types [22].”
BackgroundCid, M. C., Font, C., Coll‐Vinent, B., & Grau, J. M. (1998) · Current Opinion in Rheumatology · doi:10.1097/00002281-199801000-00004 · Cited by 87
Pons, G., Raefsky, C., Carothers, D. J., Pepin, R. A., Javed, A. A., Jesse, B. W., Ganapathi, M. K., Samols, D. R., & Patel, M. S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1422 · Cited by 87 · cited 5×
“Mutational burden was compared between RA and OA for each fragment within the MT-ND1 amplification region and for the amplified DLD region, using a two-tailed Fisher's exact test.”
MethodInfluentialMitochondrial repair of 8-oxoguanine and changes with aging
Stevnsner, T., Thorslund, T., de Souza-Pinto, N. C., & Bohr, V. A. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00142-0 · Cited by 86 · cited 1×
“The mtDNA is in close physical proximity to the free-radical-producing process of oxidative phosphorylation and lacks the protective nucleosome structure found in nuclear DNA [23].”
BackgroundIdentification of two missense mutations in a dihydrolipoamide dehydrogenase-deficient patient.
Liu, T. C., Kim, H., Arizmendi, C., Kitano, A., & Patel, M. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5186 · Cited by 81 · cited 4×
“The same amplification and sequencing procedure as above was followed using PCR primers (Table 1) and conditions previously published for a nuclear gene, that for dihydrolipamide dehydrogenase (DLD) [18,19].”
MethodInfluentialScott, B. B., Weisbrot, L. M., Greenwood, J. D., Bogoch, E. R., Paige, C. J., & Keystone, E. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400315 · Cited by 77 · cited 1×
“Synovial fibroblast lines derived from the synovial tissue were established as previously described [15].”
ResultSelf-citationSchmits, R., Kubuschok, B., SCHUSTER, S., PREUSS, K.-D., & Pfreundschuh, M. G. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01751.x · Cited by 46 · cited 2×
“Moreover, one of these autoantigens is a mtDNA-encoded subunit of complex IV (cytochrome c oxidase subunit II [28]), implicating mtDNAderived proteins in autoimmune disease.”
BackgroundRole of MHC Class I in Immune Surveillance of Mitochondrial DNA Integrity
Gu, Y., Wang, C., Roifman, C. M., & Cohen, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3603 · Cited by 29 · cited 2×
“There is growing evidence that somatic mutations within protein-coding genes of mtDNA may be recognized by the immune system: damaged mtDNA results in increased expression of MHC class I; and both MHC class I and class II can present mitochondrial peptides [11,12].”
BackgroundSuppression of Type II Collagen-Induced Arthritis by N-Acetyl-l-Cysteine in Mice
Kröger, H., Miesel, R., Dietrich, A., Ohde, M., Altrichter, S., Braun, C., & Ockenfels, H. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00570-8 · Cited by 25 · cited 1×
“The NADPH oxidase system of neutrophils and monocytes produces ROS upon activation [26].”
Background
Cited by
Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis
Bartok, B., & Firestein, G. S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00859.x · Cited by 1,906
Synovial inflammation in osteoarthritis progression
Sanchez-Lopez, E., Coras, R., Torres, A., Lane, N. E., & Guma, M. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00749-9 · Cited by 1,041
Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes
Nygaard, G., & Firestein, G. S. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0413-5 · Cited by 928
Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors
Bottini, N., & Firestein, G. S. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.190 · Cited by 907
Hypoxia, oxidative stress and inflammation
McGarry, T., Biniecka, M., Veale, D. J., & Fearon, U. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.03.042 · Cited by 601
Metadata
- Authors
- Da Sylva, T. R., Connor, A., Mburu, Y., Keystone, E., & Wu, G. E.
- Affiliations
- University Health Network (CA)
- York University (CA)
- Mount Sinai Hospital (CA)
- ORCID
- Keystone, Edward
- Venue
- Arthritis Research & Therapy
- Published
- 2005-04-28
- Volume
- 7
- Issue
- 4
- Pages
- R844-51
- ISSN
- 1478-6354 (ISSN-L)
- PMC
- PMC1175034
- OpenAlex
- W1598861942
- Cited by
- 73
- References
- 29
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 4 · 2022: 9 · 2021: 3 · 2020: 7 · 2019: 3 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 3 · 2014: 5 · 2013: 4 · 2012: 4
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Arthritis Research & Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- rheumatoid arthritis, mitochondrial DNA, synoviocytes, MT-ND1, NADH dehydrogenase complex I, autoimmunity, bacterial infection, osteoarthritis, mutational burden, autoimmune disease pathogenesis
- MeSH terms
- Arthritis, Rheumatoid, Cells, Cultured, DNA, Mitochondrial, Humans, Mitochondria, Mutation, Synovial Membrane
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.